Pharmacokinetics of sifuvirtide, a novel anti-HIV-1 peptide, in monkeys and its inhibitory concentration in vitro.
about
Efficacy, stability, and biosafety of sifuvirtide gel as a microbicide candidate against HIV-1Computational prediction of anti HIV-1 peptides and in vitro evaluation of anti HIV-1 activity of HIV-1 P24-derived peptides.An expanded model of HIV cell entry phenotype based on multi-parameter single-cell data.The conserved residue Arg46 in the N-terminal heptad repeat domain of HIV-1 gp41 is critical for viral fusion and entrySynergistic efficacy of combination of enfuvirtide and sifuvirtide, the first- and next-generation HIV-fusion inhibitorsNovel compounds for the treatment of HIV type-1 infection.Approaches for identification of HIV-1 entry inhibitors targeting gp41 pocket
P2860
Q28729936-0FC8C104-A1FE-49AF-B020-60C466E77786Q30368769-8C87C72C-5256-415D-AFED-C06E9052EC83Q34351378-4D15B6AB-3C13-4341-98E8-0BE3593C28ACQ34412839-51D90919-3A09-41E0-9E9C-7F7928932C27Q37225141-CCCDE9CF-6814-4AE6-9E4B-04D53B7FE7D5Q37502492-B2B47F49-9970-4CAA-99CE-6AB4351D2909Q38076321-664CDEF7-645B-48FD-ABE1-A466C3607AA2
P2860
Pharmacokinetics of sifuvirtide, a novel anti-HIV-1 peptide, in monkeys and its inhibitory concentration in vitro.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Pharmacokinetics of sifuvirtid ...... bitory concentration in vitro.
@en
type
label
Pharmacokinetics of sifuvirtid ...... bitory concentration in vitro.
@en
prefLabel
Pharmacokinetics of sifuvirtid ...... bitory concentration in vitro.
@en
P2093
P2860
P1476
Pharmacokinetics of sifuvirtid ...... bitory concentration in vitro.
@en
P2093
De-sheng Liu
Gui-fang Dou
Hai-feng Song
Liu-meng Yang
Qing Liang
Shu-jia Dai
Xiao-hong Qiang
Xiu-wen Liu
Yong-tang Zheng
Zhong-ming Tang
P2860
P304
P356
10.1111/J.1745-7254.2005.00163.X
P577
2005-10-01T00:00:00Z
P5875
P6179
1011302606